Table 3.
Remicade (infliximab) [3, 4, 14]
Initial Visit:
History and Physical
· History of CHF?
· History of malignancy or serious infections (hepatitis, TB, HIV, other)?
· History or family history of multiple sclerosis?
· History of other neurological disease including seizure disorders?
· History of COPD and smoking?
· Total body skin exam for skin cancer
· Check for HSM, cervical/axillary/inguinal lymphadenopathy
· History of diabetes?
· Have you lived in Southwest (risk of coccidiomycosis) or Southeast – Ohio and Mississippi River Valleys (risk of histoplasmosis or blastomycosis)?
· Travel to area endemic for TB?
· Live vaccine within past month – you or household member?
· Medications: Anakinra; cyclosporine; abatacept; natalizumab; other anti-TNF agents; rituximab; methotrexate; corticosteroids; cyclophosphamide (increased risk of solid malignancies in Wegener’s granulomatosis); warfarin (levels can be decreased by anti-TNF agents)
· Wegener’s granulomatosis? (increased risk of malignancy with Remicade)
· Major surgery in next month?
· Active infection? Hold dose for infection or sepsis
· For Enbrel - History of alcoholism? (increased mortality in alcoholic hepatitis)
Labs
· CBC, CMP
· TB test (for PPD, consider >5mm as positive)
· Hepatitis B screen: Hepatitis B sAg, Hepatitis B sAb, Hepatitis B cAb
· Influenza vaccine (if flu season)
· Baseline ANA (optional)
· HIV (optional) – especially with erythrodermic psoriasis
· Cardiovascular risk panel: CRP, homocysteine, HbA1C, lipid profile (if screening for psoriasis) (optional)
· Pneumovax (optional)
Administration Considerations
· Pre-medicate with acetaminophen and antihistamines
· Have acetaminophen, antihistamines, corticosteroids, and/or epinephrine available for immediate use
Counseling/Other
· Infusion reaction – ANAPHYLAXIS (e.g., angioedema; bronchospasm; hypotension), serum sickness-like reaction (polyarthralgias, myalgia, fever, rash, headache, sore throat, dysphagia, hand and facial edema), seizure
· Risk of anaphylaxis if previously had Remicade more than 6 months prior
· Can worsen existing malignancies
· Malignancy:
o Non-Hodgkin's lymphoma and Hodgkin's disease; breast, colorectal, melanoma, acute and chronic leukemia
o Lymphoma and other malignancies in children and adolescents
o Non-melanoma skin cancer with prior phototherapy
o If h/o COPD and smoking, risk of lung or head and neck malignancy
o Hepatosplenic T-cell lymphoma - all in Crohn's or ulcerative colitis, mostly adolescent or young adult males AND azathioprine or 6-mercaptopurine at or prior to diagnosis (although rheumatologists frequently use this combination)
· Risk of reactivation of latent TB
o Risk is higher with TNF-blocking monoclonal antibodies than with Enbrel
· Serious, sometimes fatal, infection (especially with methotrexate or corticosteroids): bacterial (including sepsis), mycobacterial, invasive fungal, viral, and opportunistic infections, such as tuberculosis (including reactivation), histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, listeriosis
· Exacerbation or new onset of demyelinating disease, e.g., multiple sclerosis, seizure disorder
o Rare cases of optic neuritis, seizure, CNS manifestations of systemic vasculitis, peripheral demyelinating disorders such as Guillain-Barre syndrome; Caution with pre-existing demyelinating or seizure disorders
· Can worsen moderate to severe heart failure or cause new-onset heart failure
· May lower incidence of coronary artery disease (a benefit)
· Loss of efficacy can occur with time, which is sometimes prevented with coadministration of low-dose methotrexate14.
· Works fast (PASI 50 at week 2)14 (a benefit)
· Lupus-like syndrome
· Reactivation of hepatitis B
· Hepatotoxicity - acute liver failure, jaundice, hepatitis, cholestasis, autoimmune hepatitis
· Incidence of elevated liver enzymes and liver complications is somewhat higher with Remicade than with other TNF-alpha inhibitors4.
· Cytopenias: pancytopenia, aplastic anemia, leucopenia, thrombocytopenia
· Avoid live vaccines – self and household members
· Pediatric Patients: Up to date on vaccines before starting?
· Formation of anti-Remicaide antibodies after drug-free intervals of >16 weeks, lower incidence in those taking methotrexate concomitantly, associated with decreased efficacy
· If you have diabetes, there is higher chance for infection.
· For Enbrel - If you have diabetes, there is a risk for hypoglycemia and a higher chance for infection when serum glucose is poorly controlled
· For Simponi and Remicade - New-onset or worsening psoriasis
· For Cimzia - Erroneously elevated aPPT tests
· For Cimzia - Intestinal obstruction (with Crohn's patients)
Follow-up Visit:
History and Physical
· Every six months: Total body skin exam for skin cancer
· Every six months: Check for HSM, cervical/axillary/inguinal lymphadenopathy
· Any new infection – hold dose for active infection or sepsis
· When was last dose (< 6 months?) – risk for anaphylaxis if > 6 months?
· Is there sustained clinical efficacy in the treatment interval? Skin? Joints?
· Any signs of heart failure
· Major surgery in next month?
· Other interval history
Labs
· Every visit for first 4 infusions, then approximately every three months: CBC, CMP
· Every year: TB test (consider induration of >5mm as positive)
· Influenza vaccine annually (in flu season)
· Pre-medicate with acetaminophen and antihistamines
· In HBV carriers, check liver panel for laboratory signs of hepatitis B reactivation
· ANA and anti-ds-DNA (if lupus-like symptoms)
Other
· Any live vaccines in past month?
· Any household members getting live vaccine?